Better Outcomes with Intranigral versus Intrastriatal Cell Transplantation: Relevance for Parkinson's Disease

Marine Droguerre1, Sébastien Brot1, Clément Vitrac1

  • 1Laboratoire de Neurosciences Expérimentales et Cliniques, Inserm, Université de Poitiers, 86022 Poitiers, France.

Cells
|April 12, 2022
PubMed
Summary

Intranigral grafts for Parkinson's disease show better dopaminergic neuron survival and motor skill recovery than intrastriatal grafts. Homotopic placement is key for successful cell transplantation and basal ganglia rewiring.